CAS 899821-23-9
:ACP-105
Description:
ACP-105, with the CAS number 899821-23-9, is a synthetic compound that functions as a selective androgen receptor modulator (SARM). It is designed to selectively bind to androgen receptors in muscle and bone tissues, promoting anabolic effects while minimizing androgenic side effects typically associated with traditional anabolic steroids. ACP-105 has been studied for its potential applications in muscle wasting conditions, osteoporosis, and other disorders where muscle and bone health are compromised. The compound exhibits a favorable pharmacokinetic profile, which includes oral bioavailability and a relatively long half-life, making it a candidate for therapeutic use. Its selectivity for androgen receptors allows for targeted action, potentially leading to improved muscle mass and strength without the adverse effects on the prostate or other androgen-sensitive tissues. However, as with many SARMs, the long-term safety and efficacy of ACP-105 in humans remain under investigation, and it is not approved for clinical use in many jurisdictions.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
ACP-105
CAS:<p>ACP-105 is a novel and potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen</p>Formula:C16H19ClN2OPurity:99.89%Color and Shape:SolidMolecular weight:290.792-Chloro-4-((3-Endo)-3-Hydroxy-3-Methyl-8-Azabicyclo[3.2.1]Octan-8-Yl)-3-Methylbenzonitrile
CAS:2-Chloro-4-((3-Endo)-3-Hydroxy-3-Methyl-8-Azabicyclo[3.2.1]Octan-8-Yl)-3-MethylbenzonitrilePurity:97%Molecular weight:290.79g/mol



